Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor

Published:2013-09-06 Issue:10 Volume:4 Page:994-999
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Borretto Emily¹,Lazzarato Loretta¹,Spallotta Francesco²,Cencioni Chiara²,D’Alessandra Yuri²,Gaetano Carlo³,Fruttero Roberta¹,Gasco Alberto¹

Affiliation:

1. Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Via Pietro Giuria 9, 10125 Torino, Italy

2. Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Centro Cardiologico Monzino—IRCCS, Via Carlo Parea 4, 20138 Milan, Italy

3. Division of Cardiovascular Epigenetics, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml400289e

Reference28 articles.

1. Acetylation and chromosomal functions

2. NO sparks off chromatin: Tales of a multifaceted epigenetic regulator

3. Histone deacetylases—an important class of cellular regulators with a variety of functions

4. Novel Structural Insights into Class I and II Histone Deacetylases

5. Histone deacetylase inhibitors: Keeping momentum for neuromuscular and cardiovascular diseases treatment

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy;European Journal of Medicinal Chemistry;2023-11

2. Molecular structure of 3,3-pentamethylenediaziridine in gas and solution phases;Mendeleev Communications;2023-09

3. Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors;Molecules;2023-07-27

4. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06

5. The current scenario of furoxan hybrids with anticancer potential;Journal of Heterocyclic Chemistry;2023-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3